Event Content

The biotech industry is poised for recovery as IPOs and corporate dealmaking gain momentum in 2025, driven by renewed investor confidence and strategic activity within the sector. A combination of increased M&A interest, evolving investor preferences, and alternative capital-raising options highlights the ...

• Alternative Approaches to Boost Patient Enrolment Amid Recruitment Challenges • How the Rising Pressures of Patient Recruitment Are Challenging Traditional Enrolment Methods

Are you ready to take your drug formulations to the next level? Don’t miss this game-changing presentation on how combining Wet Bead Milling with Spray Dried Dispersion—also known as spray drying of API nanosuspensions—can revolutionize your approach to drug delivery and improve the outcomes of your clinic...

In today’s evolving healthcare landscape, centering the patient voice is more crucial than ever. Join our keynote as we explore how integrating patient perspectives enhances clinical outcomes, drives innovation, and fosters trust across the industry.

Late differentiation solutions have become a cornerstone of outsourcing strategies, addressing critical challenges such as flexibility, regulatory compliance, and cost and material optimization. This keynote will explore how innovative packaging technologies, such as shrink sleeve labels, meet these demand...

The presentation will delve into how the LOG Pharma Primary Packaging team have addressed the challenge of designing eco-friendly oxygen and moisture barrier bottles. It will highlight the complexities of developing sustainable primary packaging for pharmaceuticals that comply with environmental standard...

The current exemptions from PPWR and the like which are afforded to pharma packaging won't last forever. In this session we shall explore sustainable solutions that are being delivered industry wide, as well as considering specific material changes which can reduce overall carbon emissions.

This presentation addresses quality control and compliance challenges throughout the packaging and drug delivery journey, emphasizing the risk of errors at each handoff in the workflow. It demonstrates how GlobalVision's automated proofreading and quality inspection tools ensure accuracy at every stage, em...

• China DMF Regulatory Framework • China DMF Pathways • Comparison between China DMF, US DMF, EU CEP and ASMF • China DMF requirements, timelines and costs • Tips & Pitfalls

Andrea Robbiani, Business Development Executive for Smart Manufacturing, highlights innovative technologies and solutions aimed at optimising processes and driving efficiency in the pharmaceutical industry, presented at CPHI Milan.

Ensuring accurate potency testing and maintaining product purity are crucial in antibody-drug conjugate (ADC) development, scale-up, and commercialization. Innovative solutions, including effective tools and streamlined processes, are necessary for efficient production of ADCs for clinical trials and comme...

Join our panel of experts, where we delve into the new frontier in formulation development and how the pharma ecosystem in the Middle East are looking to shape next-generation development

Excipients for pharmaceutical processes – How to identify opportunities for novel excipients that solve formulation and process challenges"; Needs of the industry for novel excipients, ways to identify current gaps and work together to resolve them, 1-2 key examples of common process challenges that might ...

Drug development, particularly of biologics can be expensive and run over several years. One of the challenges for formulation and clinical development teams is identifying devices for use in early formulation and clinical studies, where the performance characteristics and clinical safety are being assesse...

Proper definition of sterilization and max dose values is critical to the creation of a robust radiation sterilization process as part of your product’s route to market. Radiation Technology Center Senior Manager Pierre Reppert shares best practice for processing samples to define these values for gamma, e...

After years of investment in research & development, pharmaceutical companies have brought to the market a growing number of new therapies based on mRNA or viral vector technology, which require storage at freezing temperatures. Deep cold storage poses great challenges to the primary packaging container....

Development of bio-therapeutics often rely on small-scale single-use bioreactors made from plastics that include versatile connectors for easy connection and fast turnaround. As bio-therapeutic development continues to grow, industry front runners have defined challenging sustainability environmental targe...

>R&D Review – What are the Therapies of the Future?

Though viral vectors are used extensively in cell and gene therapy, the challenges of manufacturing such complex biologics at industrial scale is still a limitation to its broader use.
Dr. Ayuso will speak about how upstream and downstream process optimization using design of experiments (DOE), a p...

Blow-fill-seal (BFS) technology is being explored for one-dose presentations of vaccines and other biologics, providing a continuous, automated process that can lower manufacturing costs, increasing access for patients worldwide. Other BFS benefits for biologics developers include enhanced automated p...

• GUCY2C is a mucosally-restricted, immunologically compartmentalized self-antigen overexpressed in GI adenocarcinomas • GUCY2C Vaccination in MRD (minimal residual disease) setting for recurrence prevention • GUCY2C adoptive cell therapy for treatment of metastatic GI cancers

With US Pharma pledging to become net-zero by 2050, you must have the right processes. Join our focused panel where our experts will discuss the best ways to implement ESG in your organization: • Defining ESG in Pharma to understand what makes it different from other industries • Establishing what i...

Join our focused session, where our market expert will provide an insightful analysis of the supply chain set-up from the pandemic to now. Understand the industry learnings from Covid and what has evolved within the supply chain industry: • Reviewing current developments in pharmaceutical supply chain ...

Where QBD was the orchestral sheet music that determined how drug product development has been harmonized over the last 15 or so years, contemporary patient-centric risk-based approaches to drug development are the pop evolution. The music is still beautiful when produced well - but the focus is no longer...

Transitioning drugs from IV to subcutaneous (SC) delivery brings new requirements and impacts program considerations for combination product development. In this session, we identify trade-offs that pharma weighs to de-risk combination product development programs involving large volume subcutaneous (LVSC...

Advances in auto-injector design now provide the option to use both 1ml and 2.25mL syringes plus employ technology to adapt to varying fill volumes and viscosities all whilst maintaining the same device form. This provides a solution for the formulation changes that take place during drug development, clin...

The presentation will focus on pressing over the pain points of Pharma Manufacturing, where we present the ECOSYSTEM of Körber Pharma as a great solution. I plan to address the burning questions - What is an Ecosystem and why is it so important in Pharma Manufacturing? The specific details on exploring ...

As the number of patients managing chronic diseases continues to increase, self-injection solutions play an important role in enabling the shift towards home care. Identification of potential use errors is a critical task during device development to support patient acceptance and usability. The design of ...

In this webinar, formulation scientists and pharmaceutical development specialists will learn how Lonza’s Capsule Applications Services lab can address drug solubility limitations, develop innovative capsules to tailor drug delivery, and optimize encapsulation processes.


Click here to ...

With this session you will learn about best practices in Green Chemistry metrics for evaluating the impact of waste in pharmaceutical drug substance manufacturing, and their limitations, in the context of API lifecycle assessment. You will also be informed about the new iGAL 2.0 metric as a valuable extens...

In Dec 2021, Thermo Fisher completed the acquisition of PPD, Inc, a leading global provider of clinical research services to the biopharma and biotech industry. With the addition of PPD, Thermo Fisher will offer a comprehensive suite of world-class services across the clinical development spectrum – from s...

An investigational large volume subcutaneous wearable injector delivered 5mL viscous placebo injections to healthy adults with favorable subject tolerability and acceptability. This session outlines:
• An investigational large volume subcutaneous wearable injector was evaluated for feasibility of 5...

The presentation will be about the Gerresheimer – roadmap to decarbonization. The speaker will cover supplier-specific approaches like the furnace technology. Furthermore, Value-chain-comprising approaches in Ph-business (eg eco-design development) will be explained. In the end, success stories about joint...

In this webinar, originally part of Pharmapack Europe 2022, Thomas Watts, Engineering Consultant, Team Consulting discusses tackling the challenges of cloud connectivity. The electronic Product Information initiative for Medicines (ePI) aim to ease the accessibility on product information to everyone with...

In this webinar, originally broadcast as a part of Pharmapack Europe, speaker Holger Krenz, Vice President Applications Development Europe, SiO2 Materials Science discusses: • Introduction SIO2 Materials Science / Technology, defect modes biological drugs vs. primary packaging • Case Study Novartis...

In this webinar, originally broadcast as part of the Pharmapack Europe show, Stefan Lutzmayer, Consultant, IQVIA discusses how as biologics and specialty medicines increase in importance in global healthcare, especially when access to medicines and biosimilars become growth areas, this brings various oppor...

In this webinar is originally broadcast as part of CPHI North America, with speakers Robert Bloder, Chief Business Officer, Ascendia Pharma, Chris Senanayake, CEO & CSO, TCG GreenChem, Inc. and John Pennett, Partner-in-Charge of the National Technology and Life Sciences Group, EisnerAmper. The thread line:...

In this session, originally broadcast as part of the CPHI North America content programme, Pfizer CentreOne’s presenters, Tom Wilson and Nicole Strauss will take a deep dive into the recipe for supply chain management success in the face of capacity challenges. Solving those challenges revolves around t...

Merger, acquisition, and consolidation activity in CRO/CDMO world has intensified to the point where many of my colleagues are beginning to wonder how big the global players can actually become. While many of the mid-sized players have disappeared, a huge number of small pharma service organizations are th...

As the healthcare landscape continues to change, the results can deeply impact the economics of a practice. This session will discuss medical vs pharmacy benefit trends, PBMs, national and government payer changes, and how to stay five steps ahead for community based physicians and infusion centers. This s...